Based on the presence of endocrine receptors such as estrogen receptors (ER), progesterone (PR) and epidermal growth factor 2 (HER2), there are several biological types of breast cancer that differ in their sensitivity/resistance towards the applied therapy [2]. This evidence concerns the gene ERBB2 and breast carcinoma.